Medicilon/MPI Preclinical Research-Shanghai has received accreditation to conduct GLP studies that meet US FDA standards. Shanghai Medicilon and MPI Research of Michigan (USA) announced the formation of a JV offering pre-clinical CRO services in December 2007. Its 50,000 square foot lab, which was completed in February 2008, is located in Shanghai’s Chuansha Economic Park. GLP certification was a goal of the JV from its start, according to Jintao Zhang, PhD, who is CEO of the China JV. More details...